And then this in your note! Hehehe
$Marinus Pharmaceuticals(MRNS.US$ Topline data from the TrustTSC trial is anticipated in the first half of the fourth quarter of 2024. Marinus is targeting submission of a supplemental New Drug Application to the U.S. Food and Drug Administration in April 2025 with priority review requested.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
STD0313 : what is up with the huge drop from 10 to 1 dollar......MM making room for themselves? Did they file something late.....took a very quick scan and didn't see anything
TrytosaveabitOP STD0313: So this is how I see it! Bad earnings. Hedge funds shorting! Also when you have 50% of the daily volume going off exchange, it keeps a buying pressure of the board that would move price up. Take yesterday! Volume was just over 900K and damn close to 500K of that was routed off exchange! Kinda criminal IMO! There is over 5M shares sold short!